TIC · TIC Solutions
Conviction · Medium · more likely to lead the S&P 500 over the next three months, by a modest margin
Wrong if: a daily close below $10.00
Note written ·
How this view changed
- · Rating raised from Low to Medium. Results, 5 November 2026: Q3 2026 organic growth reached 8.4% (2.5% in Q2), Inspection & Mitigation revenue rose about 8.5%, and FY2026 revenue guidance was raised to $2,240-2,270M.
Price against the kill line
6.2% clear of its kill line on the 13 November 2026 close.
How to read this
The red mark is the price level of the published kill line: a close through it (a weekly close, on a weekly line) would prove the research note wrong on price. The dot is where the stock closed on 13 November 2026; a dot left of the mark has closed through its line.
The scale is stretched near the line, so close calls are easy to see. More than 8% from the line, the stock reads well clear, with a hollow dot to show the figure is off the drawn scale.
The kill line is the research note's own test. The portfolio sells on business facts, not on a price. How the portfolio decides
Three months against the kill line
Daily closes, to . Red: the kill line, a daily close below $10.00, on record since 11 November 2026. The shares are up 10.5% since the close; the S&P 500 is down 2.1% over the same sessions. Figures in the note can cover a different window.
Kill line
A daily close below $10.00, the 28 October 2026 close before the Q3 report, which would erase the post-report gain. A business break would also end the case: Q4 Inspection & Mitigation revenue falling again, or FY2026 revenue guidance cut below $2,240M.
Research onlyNot in the portfolio.
Key figures from the filings · Industrials
Quarter to 30 September 2026, filed 5 November 2026; valuation at the 13 November 2026 close
- Revenue, latest quarter ($M)
- 640
- Revenue, change on a year (%)
- +35.0
- Gross margin (%)
- 35.4
- Operating margin (%)
- 2.5
- Free cash flow, four quarters ($M)
- 34.2
- Net cash, cash less debt ($M)
- −1,412
- Enterprise value to sales (×)
- 1.7
- Free-cash-flow yield (%)
- 1.5
All filed numbers
What TIC Solutions reports to the SEC in its quarterly and annual filings. Each group states its period and filing date once; a figure dated otherwise says so. Built from the filings known on .
| Quarter to | Revenue ($M) | On a year (%) | Gross margin (%) | Operating margin (%) |
|---|---|---|---|---|
| first filed | 640 | +35.0 | 35.4 | 2.5 |
| first filed | 584 | +86.1 | 34.9 | 1.9 |
| first filed | 488 | +108.4 | 33.1 | −6.0 |
| first filed | 508 | +94.0 | 35.2 | −3.8 |
| first filed | 474 | — | 32.2 | −1.4 |
| first filed | 314 | +1.5 | 23.6 | 5.8 |
| Pre-tax income ($M) | −12.3 |
| Net income ($M) four quarters: −113 | −11.1 |
| Diluted shares, change on a year (%) | Not reported |
| Operating cash flow ($M) | 86.3 |
| Capital spending ($M) | 52.1 |
| Free cash flow ($M) | 34.2 |
| Cash and short-term investments ($M) | 198 |
| Debt ($M) long-term debt | 1,610 |
| Net cash, cash less debt ($M) | −1,412 |
| Deferred revenue ($M) +35.4% on a year | 63.1 |
| Backlog, orders not yet delivered ($M) +30.0% on a year | 1,300 |
| Receivables ($M) | 471 |
| Inventory ($M) | Not reported |
| Shareholders' equity ($M) | 2,108 |
| Market value ($M) | 2,318 |
| Enterprise value, market value plus net debt ($M) | 3,729 |
| Enterprise value to sales (×) | 1.7 |
| Enterprise value to operating income (×) | Not meaningful |
| Price to earnings (×) | Not meaningful |
| Price to book value (×) | 1.1 |
| Free-cash-flow yield (%) | 1.5 |
Short interest (FINRA, settled 15 October 2026, published 26 October 2026): 10.3% of shares outstanding sold short, 16.9 days of average trading to cover, +6.5% since the previous report.
| Window | Bought | Sold |
|---|---|---|
| 90 daysfrom | $0 | $0 |
| 12 monthsfrom | $0 | $503K |
The thesis
TIC Solutions' recovery case has moved from forecast to first confirmation: the third-quarter 2026 report on 5 November 2026 showed 8.4% organic growth and Inspection & Mitigation revenue up about 8.5%, and the next test is whether that holds in the fourth quarter without the help of shifted work. The company raised full-year revenue guidance to $2,240–2,270 million, above the $2.218 billion consensus cited by Benzinga on 5 November 2026.
The adjusted daily close was $10.99 on 10 November 2026, up from $10.00 on 28 October 2026, and 5.6% below the 52-week high of $11.64. The story is well known: the recovery story is well known, and the November report supplied the evidence that the August upgrades from UBS and JPMorgan anticipated.
Cash is the weaker side of the report. Cash fell to $197.9 million at 30 September 2026 from $362.4 million at 30 June 2026, after $180.0 million of acquisitions in the first nine months of 2026, and term loan debt stayed at $1.6 billion.
Bullish and bearish views on TIC Solutions, Inc
The bull case on TIC Solutions, Inc (TIC), in brief: organic growth inflected. The bear case: the inspection rebound may be timing.
Bull case
- Organic growth inflected. Q3 revenue was $639.6 million, up 35% as reported and 12.5% on a combined basis, including 8.4% organic growth, per the company's 8-K of 5 November 2026. Organic growth was 2.5% in Q2 and 2.2% in Q1.
- Legacy inspection returned to growth. Inspection & Mitigation revenue was $318.2 million, up about 8.5%, after falling about 5.5% combined in Q2. Adjusted gross margin in the segment rose to 29.2% from 28.3%, per the 8-K. UBS had forecast this return to growth on 11 August 2026.
- Backlog keeps building. Combined Consulting & Engineering and Geospatial backlog reached a record $1.29 billion, up 23% year over year, against $1.18 billion at the Q2 report on 6 August 2026. Consulting & Engineering revenue was $223.2 million, up from $206.6 million in Q2.
- Guidance rose and tightened. Full-year revenue guidance moved to $2,240–2,270 million from $2,150–2,250 million. Adjusted EBITDA (earnings before interest, taxes, depreciation and amortization, adjusted by the company) guidance narrowed to $342–350 million from $330–355 million, per the 8-K.
- Margins edged up. Q3 adjusted EBITDA was $107.2 million, a 16.8% margin, against $94.8 million and 16.2% in Q2. Management said on the earnings call it does not expect further margin degradation in Q4.
Bear case
- The inspection rebound may be timing. The company attributed the segment's growth to callout, outage and capital project activity, including work shifted from Q2. A Finviz analysis of 5 November 2026 described part of the rebound as new site ramps and outage timing rather than a new run rate.
- Cash fell sharply. Cash was $197.9 million at 30 September 2026 and liquidity $293.3 million, against $362.4 million and $473.5 million at 30 June 2026, per the 8-Ks. Nine-month operating cash flow was $36.6 million against $39.5 million of capital spending, per the 10-Q cash flow statement.
- Earnings per share missed. GAAP diluted loss per share was $(0.05) against a consensus of $0.01, per the 5 November 2026 news summary. Adjusted diluted EPS was $0.18 per the 8-K; sources disagree on the adjusted consensus.
- Debt remains heavy. Term loan debt was $1.6 billion at 30 September 2026, so results stay sensitive to interest rates and credit conditions.
- Quantitative ratings were negative. Weiss Ratings reiterated a sell (D-) rating on 4 September 2026, per MarketBeat. No later rating change was found.
Price setup
The adjusted daily close was $10.99 on 10 November 2026. The 52-week high is $11.64, and the shares sit 5.6% below it. The shares rose 7.9% over three months; the 14-day relative strength index (RSI, a momentum gauge where readings above 70 are conventionally called overbought) was 66.4.
Earlier closes in the same series were $10.00 on 28 October 2026, $8.67 on 15 October 2026 and $8.26 on 2 October 2026, the early-October low. The advance from that low is about 33%, and it came both before and after the results.
Analyst targets on record predate the report. UBS's target is $12.50 (Buy, 11 August 2026) and JPMorgan's is $11.00 (Neutral, 21 August 2026). MarketBeat's forecast page, retrieved 11 November 2026, lists an average target of $12.00 from seven analysts, with a high of $15.00 and a low of $10.00. Post-report target changes were not found.
Catalysts ahead
- early 2027 (est.): Q4 and full-year 2026 results; date not announced. Shows whether inspection growth and 8.4% organic growth hold without shifted work, and whether FY2026 guidance was met.
Elapsed catalysts
- 9 November 2026: Company announced participation in upcoming investor conferences. Management commentary on Q4 inspection volumes, cash use and margins can confirm or weaken the Q3 recovery. (passed)
What would change the view
A daily close below $10.00, the 28 October 2026 close before the Q3 report, which would erase the post-report gain. A business break would also end the case: Q4 Inspection & Mitigation revenue falling again, or FY2026 revenue guidance cut below $2,240M.
The risks this note tracks, each with what would confirm it:
- The Q3 inspection rebound reflects timing, including work shifted from Q2, rather than a lasting run rate. Confirmed by: Q4 2026 Inspection & Mitigation revenue declines year over year or organic growth falls back toward the 2.2-2.5% of the first half.
- Cash drain from acquisitions and capital spending, with $1.6B of term debt, narrows financial flexibility. Confirmed by: cash or liquidity falling further below the $197.9M and $293.3M reported at 30 September 2026 without matching earnings growth.
- Guidance is cut after the November raise. Confirmed by: FY2026 revenue guidance below $2,240M or adjusted EBITDA guidance below $342M.
What it trades with
TIC trades on its own recovery evidence: inspection volumes, engineering backlog and leverage. No current theme carries the name. Its Consulting & Engineering and Geospatial segments depend on infrastructure and utility spending, and its $1.6 billion of term debt makes the shares sensitive to interest-rate moves and credit conditions. Data vendors still list some coverage under the former name Acuren.
The evidence, claim by claim (8)
- Q3 2026 revenue $639.6M, +35% reported, +12.5% combined and +8.4% organic (Q2 organic +2.5%); adjusted EBITDA $107.2M, 16.8% margin; GAAP diluted EPS $(0.05), adjusted diluted EPS $0.18. Q3 2026 earnings release / 8-K · as of
- Inspection & Mitigation revenue $318.2M, up about 8.5%, adjusted gross margin 29.2%; Consulting & Engineering revenue $223.2M; Geospatial revenue $98.3M. Q3 2026 earnings release / 8-K · as of
- Record combined Consulting & Engineering and Geospatial backlog of $1.29B, +23% year over year. Q3 2026 earnings release / 8-K · as of
- FY2026 revenue guidance raised to $2,240-2,270M from $2,150-2,250M; adjusted EBITDA guidance narrowed to $342-350M from $330-355M; consensus revenue estimate was $2.218B. Q3 2026 earnings release; Benzinga · as of
- Cash $197.9M and total liquidity $293.3M at 30 September 2026, versus $362.4M and $473.5M at 30 June 2026; term loan debt $1.6B. Q3 and Q2 2026 earnings releases · as of
- First nine months of 2026: acquisitions net of cash $180.0M, share repurchases $22.7M, operating cash flow $36.6M, capital spending $39.5M. Q3 2026 earnings release / 10-Q · as of
- UBS Buy with $12.50 target (11 August 2026) and JPMorgan Neutral with $11.00 target (21 August 2026); MarketBeat lists a $12.00 average target from seven analysts. UBS and JPMorgan notes via Benzinga, Investing.com; MarketBeat · as of
- Adjusted daily close $10.99, 5.6% below the $11.64 52-week high; 3-month price change +7.9%; 14-day RSI 66.4. Split/dividend-adjusted daily bars · as of
Sources